Magnesium sulphate vs placebo (outcomes
Death or major neurodevelopmental disability · women at risk of preterm birth (< 34 weeks' gestation)
Magnesium sulphate showed no clear difference in death or major neurodevelopmental disability (up to school age)** compared with placebo (outcomes (low certainty).
1 finding from 1 review
- Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus 2024 · Cochrane Headline outcomes onlyRR 0.81 [0.59, 1.12]1 study · 503 participantsLow